PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon)
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexMale
Age18-40
SponsorUniversity of Miami
About this trial
The purpose of this research study is to look at whether Eroxon® gel when used together with tadalafil, may help improve erectile function in men ages 18 to 40 who have type 2 diabetes.
Eligibility criteria
Qualifiers
Male sex at birth
Age 18-40 years
Diagnosis of type 2 diabetes mellitus
Diagnosis of erectile dysfunction
Disqualifiers
Type 1 diabetes mellitus
Severe psychiatric illness that would impair participation
Use of nitrates or contraindications to sexual activity
Known allergy to Eroxon® gel components
Trial design
Treatments tested in this trial
- Eroxon®
- tadalafil
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Miami
Lead sponsor
Sexual Medicine Society of North America Inc.
Collaborator
Source ClinicalTrials.gov